Your Messages Inbox
Your Article Summary
See Latest ArticlesRISPERDAL CONSTA (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder
Janssen, 05/28/09
New data demonstrate that maintenance therapy with RISPERDAL CONSTA Long-Acting Treatment significantly delayed the time to relapse compared to placebo in patients with Bipolar I Disorder. Results of the study were presented this week at a major medical meeting.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Lundbeck initiates clinical phase II trials with Lu AE58054 as augmentation treatment in Alzheimer's disease
Lundbeck, 11/30/09
Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09
A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimers disease: a post hoc analysis
Current Medical Research and Opinion, 11/25/09
Article Search
Sponsor